01 Aug, EOD - Indian

SENSEX 80599.91 (-0.72)

Nifty IT 34649.6 (-1.85)

Nifty Midcap 100 56637.15 (-1.33)

Nifty Pharma 22011.7 (-3.33)

Nifty Bank 55617.6 (-0.62)

Nifty Next 50 66192.8 (-1.35)

Nifty Smallcap 100 17668.2 (-1.66)

Nifty 50 24565.35 (-0.82)

01 Aug, EOD - Global

NIKKEI 225 40799.6 (-0.66)

HANG SENG 24507.81 (-1.07)

S&P 6276.5 (-1.72)


Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(01 Aug 2025, 15:04)

P&G Health spurts after PAT climbs over threefold to Rs 66 cr in Q1 FY26

Procter & Gamble Health surged 7.66% to Rs 6,351.50 after the company’s standalone net profit soared 294.4% to Rs 66.18 crore in Q1 FY26 compared with Rs 16.78 crore in Q1 FY25.


Revenue from operations jumped 19.33% YoY to Rs 338.74 crore in Q1 FY26, driven by broad-based growth in domestic and exports business.

Profit before tax (PBT) zoomed 289.01% to Rs 88.81 crore during the quarter, compared with Rs 22.83 crore posted in same quarter last year.

Milind Thatte, managing director, P&G Health India, said, "We are pleased with the continued momentum and strong start to the Financial Year 2025-26. These results are a reflection of our commitment towards addressing the evolving needs of our consumers and healthcare professionals, via superior brand building and go to market initiatives while improving supply chain capabilities.

He further added, “Our strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption and an agile accountable organization, is delivering balanced and sustainable growth results. We continue to drive engagement for our consumers and healthcare professionals alike, through innovation backed by science and meaningful interventions to make life a little better every day.”

Procter & Gamble Health (P&G Health) is one of India's largest VMS companies, manufacturing and marketing vitamins, minerals, and supplements products that include Neurobion, Livogen, SevenSeas, Evion, Polybion, and Nasivion.

More News
More Company News View Company Information

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +